{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:50:28Z","timestamp":1789869028995,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ms. Kanae Misumi"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jns.2016.01.047","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T20:51:34Z","timestamp":1453495894000},"page":"278-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice"],"prefix":"10.1016","volume":"362","author":[{"given":"Yoshihiko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Satho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.01.047_bb0005","first-page":"e46","article-title":"Heart disease and stroke statistics\u20142010 update: a report from the American Heart Association","volume":"121","author":"Writing Group","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2016.01.047_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2015.06.004","article-title":"Pharmacological therapy of acute ischaemic stroke: achievements and problems","author":"Moretti","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jns.2016.01.047_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000362719","article-title":"Imaging of acute ischemic stroke","volume":"72","author":"El-Koussy","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2016.01.047_bb0020","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.1523\/JNEUROSCI.2435-08.2008","article-title":"The HMGB1 receptor RAGE mediates ischemic brain damage","volume":"28","author":"Muhammad","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jns.2016.01.047_bb0025","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1523\/JNEUROSCI.3815-05.2006","article-title":"HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain","volume":"26","author":"Kim","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jns.2016.01.047_bb0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1423-0127-19-34","article-title":"The role of thrombomodulin lectin-like domain in inflammation","volume":"19","author":"Li","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jns.2016.01.047_bb0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2016.01.047_bb0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/cei.12106","article-title":"Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome","volume":"173","author":"Kudo","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jns.2016.01.047_bb0045","doi-asserted-by":"crossref","first-page":"R203","DOI":"10.1186\/cc8210","article-title":"Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model","volume":"13","author":"Iba","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.jns.2016.01.047_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SHK.0b013e3181d492e4","article-title":"Recombinant thrombomodulin prevents heatstroke by inhibition of high-mobility group box 1 protein in sera of rats","volume":"34","author":"Hagiwara","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.jns.2016.01.047_bb0055","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/bph.12396","article-title":"Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats","volume":"170","author":"Tanaka","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jns.2016.01.047_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2013.11.003","article-title":"Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis","volume":"79","author":"Tanaka","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2016.01.047_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/SHK.0b013e318204c019","article-title":"Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial","volume":"35","author":"Aikawa","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.jns.2016.01.047_bb0070","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/cc10228","article-title":"Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study","volume":"15","author":"Yamakawa","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.jns.2016.01.047_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2016.01.047_bb0080","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2004.00927.x","article-title":"Phase I study of a novel recombinant human soluble thrombomodulin, ART-123","volume":"2","author":"Moll","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2016.01.047_bb0085","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1538-7836.2005.01251.x","article-title":"Dose\u2013response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement","volume":"3","author":"Kearon","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2016.01.047_bb0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1160\/TH10-05-0287","article-title":"Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue","volume":"105","author":"van Iersel","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jns.2016.01.047_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2202-12-113","article-title":"Solulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in rats","volume":"12","author":"Ryang","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jns.2016.01.047_bb0100","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1538-7836.2011.04269.x","article-title":"The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model","volume":"9","author":"Su","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2016.01.047_bb0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/STROKEAHA.107.495820","article-title":"Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism","volume":"39","author":"Hayakawa","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2016.01.047_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2004.03.046","article-title":"Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice","volume":"363","author":"Egashira","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2016.01.047_bb0115","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2016.01.047_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2015.07.027","article-title":"Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication","author":"Nakano","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2016.01.047_bb0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.jcbfm.9600582","article-title":"Early release of HMGB-1 from neurons after the onset of brain ischemia","volume":"28","author":"Qiu","year":"2008","journal-title":"J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2016.01.047_bb0130","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1248\/bpb.32.1538","article-title":"Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism","volume":"32","author":"Hayakawa","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jns.2016.01.047_bb0135","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2016.01.047_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jns.2016.01.047_bb0145","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1213\/ANE.0000000000000170","article-title":"Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice","volume":"118","author":"Kawasaki","year":"2014","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jns.2016.01.047_bb0150","first-page":"614545","article-title":"Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis","volume":"2012","author":"Okamoto","year":"2012","journal-title":"Crit. Care Res. Pract."},{"key":"10.1016\/j.jns.2016.01.047_bb0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00001721-199707000-00003","article-title":"The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis)","volume":"8","author":"Mohri","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jns.2016.01.047_bb0160","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1055\/s-0037-1614900","article-title":"The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation\u2014a comparison with other anticoagulants","volume":"82","author":"Mohri","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jns.2016.01.047_bb0165","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/S0021-9258(18)83649-3","article-title":"The roles of protein C and thrombomodulin in the regulation of blood coagulation","volume":"264","author":"Esmon","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2016.01.047_bb0170","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2016.01.047_bb0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/br.2012.7","article-title":"Edaravone (radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke","volume":"1","author":"Kikuchi","year":"2013","journal-title":"Biomed. Rep."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16300478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16300478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T23:24:44Z","timestamp":1617578684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16300478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":35,"alternative-id":["S0022510X16300478"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.01.047","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}